Abstract:
Objective This study aimed to evaluate the safety and effectiveness of different anesthetic approaches and multimodal analgesia in enhanced recovery after surgery (ERAS) when applied to open pancreaticoduodenectomy patients.
Methods In this retrospective cohort study, we consecutively collected clinical data from 39 patients undergoing open pancreaticoduodenectomy in Peking Union Medical College Hospital from March 2016 to April 2018, among which 19 patients received ERAS strategy (ERAS group) and 20 traditional strategy (control group), and compared the differences in intra-operative hemodynamic changes, post-operative rehabilitation, length of stay, and costs between the ERAS group and the control group.
Results The intraoperative opioid consumption and postoperative lactic acid in the ERAS group were lower than those in the control group (both P < 0.05). White blood cell and neutrophil counts on the postoperative day 1, blood glucose, pain score, postoperative nausea and vomiting, postoperative analgesia satisfaction, time to remove the transurethral catheter and nasogastric tube, time to exhaust and ambulation, and medical costs were all improved compared to the control group (all P < 0.05). Whereas operating duration, intraoperative hemodynamic changes, and intraoperative bleeding were comparable between the two groups (all P>0.05).
Conclusion Different perioperative anesthesia plans and multimodal analgesia in ERAS strategy are safe when applied to open pancreaticoduodenectomy patients. It could effectively mitigate operative stress, decrease opioid exposure, expedite postoperative rehabilitation, shorten the length of hospital stay, and decrease medical cost.